Adjuvant hormone therapy in postmenopausal patients with locally advanced breast cancer: hope and reality
The clinical efficiency of adjuvant hormone therapy has been considered in patients with operable breast cancer in international randomized mulricenter studies. The use of aromatase inhibitors versus tamoxifen is shown to considerably improve relapse-free survival and to reduce the risk of distant metastases and contralateral breast cancer.